JP2019043957A5 - - Google Patents

Download PDF

Info

Publication number
JP2019043957A5
JP2019043957A5 JP2018210606A JP2018210606A JP2019043957A5 JP 2019043957 A5 JP2019043957 A5 JP 2019043957A5 JP 2018210606 A JP2018210606 A JP 2018210606A JP 2018210606 A JP2018210606 A JP 2018210606A JP 2019043957 A5 JP2019043957 A5 JP 2019043957A5
Authority
JP
Japan
Prior art keywords
formula
group
compound
independently
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018210606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019043957A (ja
JP6767459B2 (ja
Filing date
Publication date
Priority claimed from GBGB1315335.8A external-priority patent/GB201315335D0/en
Application filed filed Critical
Publication of JP2019043957A publication Critical patent/JP2019043957A/ja
Publication of JP2019043957A5 publication Critical patent/JP2019043957A5/ja
Application granted granted Critical
Publication of JP6767459B2 publication Critical patent/JP6767459B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018210606A 2013-08-29 2018-11-08 アミノ二酸含有ペプチド修飾剤 Active JP6767459B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1315335.8A GB201315335D0 (en) 2013-08-29 2013-08-29 Amino diacids containing peptide modifiers
GB1315335.8 2013-08-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016537416A Division JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤

Publications (3)

Publication Number Publication Date
JP2019043957A JP2019043957A (ja) 2019-03-22
JP2019043957A5 true JP2019043957A5 (enExample) 2019-05-09
JP6767459B2 JP6767459B2 (ja) 2020-10-14

Family

ID=49356024

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016537416A Pending JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤
JP2018210606A Active JP6767459B2 (ja) 2013-08-29 2018-11-08 アミノ二酸含有ペプチド修飾剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016537416A Pending JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤

Country Status (10)

Country Link
US (3) US20160207957A1 (enExample)
EP (2) EP3038658B1 (enExample)
JP (2) JP2016532705A (enExample)
KR (1) KR102461744B1 (enExample)
CN (2) CN110003055B (enExample)
AU (2) AU2014313779B2 (enExample)
CA (1) CA2922220C (enExample)
ES (1) ES2831974T3 (enExample)
GB (1) GB201315335D0 (enExample)
WO (1) WO2015028966A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
WO2017162650A1 (en) 2016-03-23 2017-09-28 Bachem Holding Ag Method for preparing glucagon-like peptides
US11338018B2 (en) 2016-12-19 2022-05-24 Harrow Ip, Llc Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
CN110294800B (zh) * 2018-03-22 2022-03-04 齐鲁制药有限公司 一种索玛鲁肽的制备方法
ES3038393T3 (en) 2018-08-09 2025-10-13 Hoffmann La Roche Cleavable linker for peptide synthesis
ES2938734T3 (es) * 2018-10-09 2023-04-14 Fresenius Kabi Ipsum S R L Procedimiento para la fabricación de análogos de GLP-1
GB201816639D0 (en) * 2018-10-12 2018-11-28 Heptares Therapeutics Ltd GLP-1 Receptor Antagonist
WO2020150262A1 (en) * 2019-01-17 2020-07-23 Harrow Ip, Llc Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
CN109776323B (zh) * 2019-01-28 2022-05-17 富乐马鸿凯（大连）医药有限公司 一种高效选择性制备脂肪二酸单叔丁酯的方法
WO2020208409A1 (en) * 2019-04-10 2020-10-15 Dr. Reddy’S Laboratories Limited Improved processes for the preparation of peptide intermediates/modifiers
CN110372785B (zh) * 2019-07-25 2020-10-23 成都诺和晟泰生物科技有限公司 一种索马鲁肽的合成方法
CN111285780A (zh) * 2020-01-16 2020-06-16 浙江工业大学 索马鲁肽侧链的汇聚式液相合成法
CN111253287A (zh) * 2020-01-16 2020-06-09 浙江工业大学 液相汇聚式合成索马鲁肽侧链的方法
CN111269137A (zh) * 2020-01-16 2020-06-12 浙江工业大学 一种液相法制备索马鲁肽侧链的方法
JP7544838B2 (ja) 2020-03-06 2024-09-03 サノフイ 選択的ｇｉｐ受容体アゴニストとしてのペプチド
HUE066991T2 (hu) 2020-08-19 2024-09-28 Sanofi Sa CRF2 receptor agonisták és terápiás alkalmazásuk
CA3230915A1 (en) 2021-09-06 2023-03-09 Thomas Boehme New peptides as potent and selective gip receptor agonists
CN115504893B (zh) * 2022-11-18 2023-03-10 成都普康生物科技有限公司 一种L-谷氨酸-α-叔丁酯的合成方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
ES2245505T3 (es) 1998-03-23 2006-01-01 Trimeris Inc. Metodos y composiciones para la sintesis de peptidos (t-20).
US6716963B1 (en) * 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
DE19924606A1 (de) * 1999-05-28 2000-11-30 Graffinity Pharm Design Gmbh Ligand-Anker-Konjugate
EP1076066A1 (en) * 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
AU1607501A (en) * 1999-11-15 2001-05-30 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US6621548B2 (en) 2001-06-15 2003-09-16 Viztec, Inc. Electrooptical displays constructed with polymer-coated elements positioned between substrates
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
JP4124734B2 (ja) * 2001-11-26 2008-07-23 アスビオファーマ株式会社 経鼻吸収用医薬組成物
CA2484594C (en) 2002-05-03 2012-06-26 Avecia Limited Process for the synthesis of peptides
SG2012000667A (en) 2003-01-08 2015-03-30 Univ Washington Antibacterial agents
US20040142379A1 (en) * 2003-01-16 2004-07-22 Carlsberg Research Laboratory Affinity fishing for ligands and proteins receptors
KR101159559B1 (ko) 2003-08-05 2012-06-26 노보 노르디스크 에이/에스 신규의 인슐린 유도체
JP5697831B2 (ja) 2003-12-03 2015-04-08 ノヴォ ノルディスク アー／エス 単鎖インシュリン
EP1718145A4 (en) * 2004-02-02 2012-03-07 Biosight Ltd CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS
WO2005082404A2 (en) * 2004-02-27 2005-09-09 Novo Nordisk A/S Glp-2 derivatives modified by lipophilic substituents
WO2006037810A2 (en) 2004-10-07 2006-04-13 Novo Nordisk A/S Protracted glp-1 compounds
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
CA2861601A1 (en) * 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
CA2665559A1 (en) 2006-10-05 2008-04-10 Lonza Ag Method for peptide synthesis
KR101046846B1 (ko) 2006-10-12 2011-07-06 동국제약 주식회사 고체상 합성법을 이용한 펩타이드의 제조방법
CN101784563B (zh) 2007-08-15 2015-02-04 诺沃-诺迪斯克有限公司 具有包括含亚烷基二醇的氨基酸的重复单位的酰基部分的胰岛素
FR2921831B1 (fr) * 2007-10-05 2014-05-09 Oreal Composition cosmetique ou dermatologique comprenant un polymere portant des groupes de jonction, et procede de traitement cosmetique
EP3673922A1 (en) * 2008-03-14 2020-07-01 VisEn Medical, Inc. Integrin targeting agents and methods of using same
MX2010009850A (es) * 2008-03-18 2010-09-30 Novo Nordisk As Analogos de insulina acilados y etabilizados contra proteasas.
CN106317164A (zh) 2008-09-12 2017-01-11 诺沃—诺迪斯克有限公司 酰化肽或蛋白的方法
CA2741921A1 (en) * 2008-11-05 2010-05-14 F. Hoffmann-La Roche Ag Neuropeptide-2-receptor (y-2r) agonists and uses thereof
JP5635529B2 (ja) * 2008-12-15 2014-12-03 ジーランド ファーマ アクティーゼルスカブ グルカゴン類似体
AU2010231126A1 (en) 2009-04-02 2011-10-13 Shire Llc Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
ME02220B (me) 2009-07-13 2016-02-20 Zealand Pharma As Analozi acilovanog glukagona
CA2776302A1 (en) 2009-10-13 2011-04-21 F. Hoffmann-La Roche Ag Neuropeptide-2 receptor (y-2r) agonists
WO2011075393A2 (en) 2009-12-18 2011-06-23 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
CN118767117A (zh) 2010-01-22 2024-10-15 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
US20130143798A1 (en) * 2010-03-26 2013-06-06 Novo Nordisk A/S Novel glucagon analogues
EP2585482B1 (en) 2010-06-24 2019-03-27 Zealand Pharma A/S Glucagon analogues
CN105037278B (zh) * 2010-07-07 2019-05-03 康奈尔大学 Sirt5调节剂及其筛选方法
JP2013209295A (ja) * 2010-10-13 2013-10-10 Takeda Chem Ind Ltd ペプチド誘導体
CA2816155C (en) * 2010-12-17 2020-10-27 Arrowhead Research Corporation Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
CN105713957B (zh) * 2010-12-22 2021-03-02 康奈尔大学 Sirt6的调节物及其筛选分析
CN102286092B (zh) 2011-09-14 2014-01-01 深圳翰宇药业股份有限公司 利拉鲁肽的固相合成方法
CN104114575B (zh) 2011-12-15 2019-04-09 爱德迪安（北京）生物技术有限公司 具有降血糖作用的化合物、组合物及其用途
SG11201403377QA (en) * 2011-12-23 2014-07-30 Zealand Pharma As Glucagon analogues
CN102584944B (zh) 2012-02-06 2014-12-17 成都圣诺生物科技股份有限公司 一种依非巴特的制备方法
EP2664374A1 (en) 2012-05-15 2013-11-20 F. Hoffmann-La Roche AG Lysin-glutamic acid dipeptide derivatives
CN102875665B (zh) * 2012-09-28 2014-11-26 深圳翰宇药业股份有限公司 一种合成利拉鲁肽的方法
CN103214568B (zh) * 2013-03-08 2014-09-24 深圳翰宇药业股份有限公司 一种固相制备促胰液素的方法
CN103242200A (zh) * 2013-04-10 2013-08-14 吉尔生化（上海）有限公司 一种Nα-芴甲氧羰基-Nε-乙酰基-赖氨酸的制备方法
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers

Similar Documents

Publication Publication Date Title
JP2019043957A5 (enExample)
AU2018250226B2 (en) Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
JP6703668B2 (ja) ペプチド合成方法
JP2016153410A5 (enExample)
TWI823054B (zh) IL-7Rα結合化合物
JP2022095872A5 (enExample)
JP2011511778A5 (enExample)
KR102461744B1 (ko) 아미노 2산을 함유한 펩타이드 변형제
JP2020063241A5 (enExample)
JP2015520184A5 (enExample)
JP2015512910A (ja) ヒトｐｄ１のｂｃループに由来する免疫調節性環状化合物
JP2007500747A5 (enExample)
JP2012512901A5 (enExample)
JP2010521485A5 (enExample)
JP2009532384A5 (enExample)
JP6703669B2 (ja) リュープロレリンの製造方法
JP2014509838A5 (enExample)
JP2009500298A5 (enExample)
JP2011530523A (ja) 酢酸グラチラマーの合成
CN107001409A (zh) 疏水性肽的制造方法
JP2018505152A5 (enExample)
JP2017518363A5 (enExample)
JP2018521977A5 (enExample)
JP7249591B2 (ja) 分解性ポリエチレングリコール結合体
JP2018536645A5 (enExample)